Key result
EPS predicts ~457% higher odds of sudden cardiac death or sustained VT in non-ischemic HFrEF.
Why the study?
Does intracardiac electrophysiological study predict the risk of ventricular tachyarrhythmias or sudden cardiac death in patients with non-ischemic HFrEF?
Meta-Analysis (n=608)
Does intracardiac electrophysiological study predict the risk of ventricular tachyarrhythmias or sudden cardiac death in patients with non-ischemic HFrEF?
Intracardiac electrophysiological study has high specificity but low sensitivity for predicting ventricular tachyarrhythmias and sudden cardiac death in patients with non-ischemic HFrEF.
Answers are grounded in this paper and cite their sources.
EPS supports arrhythmic risk stratification in non-ischemic HFrEF via high specificity; extends observational data but low sensitivity limits routine adoption.
A systematic review and meta-analysis of studies providing information on the use of intracardiac electrophysiological study (EPS) to stratify the risk of ventricular tachyarrhythmia (VT) in patients with non-ischemic chronic heart failure with low left ventricle ejection fraction (HFrEF). Relevant publications were searched until 20.01.2021 by two independent researchers in major search engines, electronic archives of clinical research, and open access preservatives repository. The end point considered was an episode of sudden cardiac death or sustained paroxysm of VT, or an appropriate electrotherapy of an implanted cardiac defibrillator. Ten clinical trials with 608 relevant patients (mean age: 51.5 ± 12 years; mean left ventricle EF: 26.8±8.5%, NYHA class: I - 17.7%; II - 33.7%; III - 35.9%, IV - 12.7%) were selected. The end point was registered in 92 patients (15.1%): in 47 patients (43.9%) with previously induced VT during EPS and in 45 patients (8.9%) without VT. The diagnostic odds ratio was 5.57 (2.27-13.63). The combined sensitivity and specificity of the EPS were 42% (26-61%) and 88% (83-92%) respectively. The results indicate the potential of EPS to stratify the arrhythmic risk in patients with non-ischemic HFrEF.
No takes yet. Share an insight, caveat, or question.
Илов et al. (2021) conducted a meta-analysis in Non-ischemic chronic heart failure with low left ventricle ejection fraction (HFrEF) (n=608). Intracardiac electrophysiological study (EPS) with induced VT vs. EPS without induced VT was evaluated on Episode of sudden cardiac death or sustained paroxysm of VT, or an appropriate electrotherapy of an implanted cardiac defibrillator (OR 5.57, 95% CI 2.27-13.63). Intracardiac electrophysiological study (EPS) stratified arrhythmic risk in non-ischemic HFrEF, predicting sudden cardiac death or sustained VT with a diagnostic OR of 5.57.
Synapse has enriched 10 related papers. Consider them for comparative context: